Pharmacokinetic/pharmacodynamic differentiation of pancreatic responsiveness in obese and lean children
β Scribed by N. Gupta; R. P. Hoffman; P. Veng-Pedersen
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 161 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.461
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The lipophilic betaβadrenoreceptor antagonist propranolol and hydrophilic atenolol have been studied to define their pharmacokinetic and pharmacodynamic characteristics in obese patients. A total of 43 subjects were allocated into three study groups: (1) healthy, lean, normolipaemic vol
The route of administration of the NSAID, flurbiprofen (sq vs. PO) resulted in positive and negative results respectively with regard to enhanced cancellous and cortical bone accumulation in the immature rat. This pharmacokinetic study was an effort to understand the pharmacodynamic difference betwe
Mivacurium, a non-depolarizing neuromuscular blocking agent, consists of three isomers; trans-trans (57%), cis-trans (36%) and cis-cis (7%). The purpose of this study was to characterize the pharmacokinetics and pharmacodynamics of mivacurium after various inputs. Four beagle dogs weighing between 7
## Abstract The combined use of lovastatin, a hypolipidemic agent effective in the reduction of cholesterol levels, and the lipophilic immunosuppressant, cyclosporine, was studied in the obese rat model. Pharmacokinetics, immunosuppressive activity, lipid levels, and creatinine clearances were comp